HSP90AA1 and prostate carcinoma: We found that HSP70 but not HSP90 (HSP90AA1) was overexpressed in enzalutamide-resistant prostate cancer cells and LuCaP CR tumors (Fig. 3a and Supplementary Fig. 2f).